Concepedia

Mélanie Tunis

MT

Statistics

Publications

5

Citations

113

H-Index

5

Active since

2004

Affiliations

Idorsia (Switzerland)(Current)

Centre National de la Recherche Scientifique

Institut de Biologie Moléculaire et Cellulaire

Mélanie Tunis is an author at Idorsia (Switzerland) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2004–2023

5

Publications

5

ACT‐1004‐1239, a first‐in‐class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases

Laetitia Pouzol, Nadège Baumlin, Anna Sassi et al. · The FASEB Journal · 2021 · 36 citations · Full text

, , +19

CXCR7 Antagonism Reduces Acute Lung Injury Pathogenesis

Laetitia Pouzol, Anna Sassi, Nadège Baumlin et al. · Frontiers in Pharmacology · 2021 · 26 citations · Full text

The binding affinity of double‐stranded RNA motifs to HIV‐1 Tat protein affects transactivation and the neutralizing capacity of anti‐Tat antibodies elicited after intranasal immunization

Charalambos D. Partidos, Johan Hoebeke, Emmanuel Moreau et al. · European Journal of Immunology · 2005 · 19 citations · Full text

, , +18

A synthetic HIV‐1 Tat protein breaches the skin barrier and elicits Tat‐neutralizing antibodies and cellular immunity

Charalambos D. Partidos, Emmanuel Moreau, Olivier Chaloin et al. · European Journal of Immunology · 2004 · 19 citations · Full text

Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes

Urs Christen, Laetitia Pouzol, Mélanie Tunis et al. · Clinical & Experimental Immunology · 2023 · 13 citations · Full text

1–5 of 5